Landscapes / Targets
TROP2
21 drugs act on TROP2, in 134 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs21
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
TROP2-targeted antibody-drug conjugate |
Kelun-Biotech +1 · Public 6990.HK · MRK |
Approved in China | Nov 2026soonPhase 3 trial completes | ||
| Next date | Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC) and 38 more | ||||
| Open drug page | |||||
TROP2-targeted antibody-drug conjugate |
Gilead (Kite) · Public GILD |
Approved | Dec 2026Phase 3 trial completes | ||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Triple Negative Breast Cancer, Metastatic Breast Cancer and 21 more | ||||
| Open drug page | |||||
TROP2-targeted antibody-drug conjugate |
Daiichi Sankyo +1 · Public AZN |
Approved | 11 Jan 2027Phase 3 trial completes | ||
| Next date | 11 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer, Breast Cancer and 28 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Jun 2027Phase 2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Non-small Cell Lung Cancer, Advanced Malignant Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2027Phase 1/2 trial completes | |||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Feb 2027Phase 1/2 trial completes | |||
| Next date | 14 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Breast Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2027Phase 1/2 trial completes | |||
| Next date | Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 2 | 30 Aug 2027Phase 2 trial completes | ||
| Next date | 30 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Advanced Breast Cancer and 2 more | ||||
| Open drug page | |||||
Sacituzumab tirumotecannot checked |
Monoclonal antibody |
Phase 2 | 30 Nov 2027Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 30 Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Epithelial Ovarian Cancer, Gastric Adenocarcinoma and 9 more | ||||
| Open drug page | |||||
— |
Biohaven · Public BHVN |
Phase 1/2 | Feb 2028Phase 1/2 trial completes | ||
| Next date | Feb 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2028Phase 1/2 trial completes | |||
| Next date | Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Biliary Tract Cancer, Breast Cancer and 19 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2029Phase 1/2 trial completes | |||
| Next date | 30 Jun 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Malignant Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Cancer, Advanced Solid Tumor and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Breast Cancer, Locally Advanced or Metastatic Digestive Tract Tumors and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Jan 2027Phase 1 trial completes | |||
| Next date | 31 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jun 2027Phase 1 trial completes | |||
| Next date | 30 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 5 Nov 2027Phase 1 trial completes | |||
| Next date | 5 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 20 of 21 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026